Item 2.02. Results of Operations and Financial Condition.

On February 4, 2020, Neurocrine Biosciences, Inc. (the "Company") held a live conference call and webcast to discuss, among other things, the Company's financial results for the fourth quarter and year ended December 31, 2019. A transcript of that conference call is attached hereto as Exhibit 99.1.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Forward-Looking Statements

Statements contained in this Current Report on Form 8-K regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Risks are described more fully in the Company's filings with the Securities and Exchange Commission, including without limitation the Company's most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Reports on Form 8-K, and other documents subsequently filed with or furnished to the Securities and Exchange Commission. All forward-looking statements contained in this Current Report on Form 8-K speak only as of the date on which they were made. The Company disclaims any obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Item 9.01. Financial Statements and Exhibits.




Exhibit    Description

             Transcript of the Neurocrine Biosciences, Inc. conference call on
  99.1     February 4, 2020

  104      Cover Page Interactive Data File (formatted as Inline XBRL with
           applicable taxonomy extension information contained in Exhibit 101)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses